Development of Fluorescent Ligands for the Human 5-HT1A Receptor

被引:25
|
作者
Alonso, Dulce [1 ]
Vazquez-Villa, Henar [1 ]
Gamo, Ana M. [1 ]
Martinez-Esperon, Maria F. [3 ]
Tortosa, Mariola [3 ]
Viso, Alma [3 ]
Fernandez de la Pradilla, Roberto [3 ]
Junquera, Elena [2 ]
Aicart, Emilio [2 ]
Martin-Fontecha, Mar [1 ]
Benhamu, Bellinda [1 ]
Lopez-Rodriguez, Maria L. [1 ]
Ortega-Gutierrez, Silvia [1 ]
机构
[1] Univ Complutense Madrid, Dept Quim Organ 1, E-28040 Madrid, Spain
[2] Univ Complutense Madrid, Dept Quim Fis 1, Fac Ciencias Quim, E-28040 Madrid, Spain
[3] CSIC, Inst Quim Organ Gen, E-28006 Madrid, Spain
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2010年 / 1卷 / 06期
关键词
G protein-coupled receptors (GPCRs); serotonin (5-HT); 5-HT1A receptor; probes; fluorescent ligands; receptor visualization; PROTEIN-COUPLED RECEPTORS; NEW-MODEL; ARYLPIPERAZINES;
D O I
10.1021/ml100053y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this work, we report the design and synthesis of a set of fluorescent probes targeting the human 5-HT1A receptor (h5-HT1AR). Among the synthesized compounds, derivative 4 deserves special attention as being a high-affinity ligand (K-i = 2 nM) with good fluorescent properties (I-em > 1000 au and a fluorescence quantum yield, Phi(f), of 0.26), which enables direct observation of the h5-HT1AR in cells. Thus, it represents the first efficacious fluorescent probe for the specific labeling of h5-HT1AR in cells. Our results provide the basis for the introduction of a variety of tags in scaffolds of G protein-coupled receptor(GPCR) ligands that enable visualization, covalent binding, or affinity pull-down of receptors. These strategies should contribute to the optimization of the therapeutic exploitation of known or new members of the GPCR superfamily by providing valuable information about their location or level of expression.
引用
收藏
页码:249 / 253
页数:5
相关论文
共 50 条
  • [1] Development and challenges in the discovery of 5-HT1A and 5-HT7 receptor ligands
    Singh, Deepika
    Singh, Priya
    Srivastava, Pooja
    Kakkar, Dipti
    Pathak, Mallika
    Tiwari, Anjani Kumar
    BIOORGANIC CHEMISTRY, 2023, 131
  • [2] Binding thermodynamics of 5-HT1A receptor ligands
    Dalpiaz, A
    Borea, PA
    Gessi, S
    Gilli, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 312 (01) : 107 - 114
  • [3] 5-HT1A RECEPTOR LIGANDS AS POTENTIAL ANTIDEPRESSANTS
    Wrobel, Martyna Z.
    Marciniak, Monika
    BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO, 2015, (05): : 28 - 39
  • [4] Development of 5-HT1A receptor antagonists
    Routledge, C
    BEHAVIOURAL BRAIN RESEARCH, 1996, 73 (1-2) : 153 - 156
  • [5] URAPIDIL ANALOGS ARE POTENT LIGANDS OF THE 5-HT1A RECEPTOR
    GROSS, G
    SCHUTTLER, K
    XIN, X
    HANFT, G
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 : S8 - S16
  • [6] Differentiation of 5-HT1A receptor ligands by drug discrimination
    Wolff, MC
    Leander, JD
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 333 (2-3) : 113 - 122
  • [7] Buspirone analogues as ligands of the 5-HT1A receptor II: Capacity factors as chromatographic parameter of lipophilicity evaluation in a series of 5-HT1A and 5-HT2A receptor ligands
    Chilmonczyk, Z
    Ksycinska, H
    Cybulski, J
    WozniakowskaSzelejewska, A
    PHARMAZIE, 1996, 51 (12): : 924 - 927
  • [8] Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands
    Ofori, Edward
    Zhu, Xue Y.
    Etukala, Jagan R.
    Peprah, Kwakye
    Jordan, Kamanski R.
    Adkins, Adia A.
    Bricker, Barbara A.
    Kang, Hye J.
    Huang, Xi-Ping
    Roth, Bryan L.
    Ablordeppey, Seth Y.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (16) : 3464 - 3471
  • [9] Synthesis of ligands with mixed 5-HT1A and 5-HT2A receptor profile
    Cybulski, Marcin
    PRZEMYSL CHEMICZNY, 2007, 86 (08): : 764 - 767
  • [10] 5-HT1A Receptor and neonatal hippocampal development
    Banerjee, P.
    JOURNAL OF NEUROCHEMISTRY, 2013, 125 : 26 - 26